{
  "items": "20",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "OneMedNet shareholders approve board elections and auditor at annual meeting",
      "url": "https://ng.investing.com/news/sec-filings/onemednet-shareholders-approve-board-elections-and-auditor-at-annual-meeting-93CH-2266921",
      "time_published": "20251224T130854",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corp (NASDAQ:ONMD) held its 2025 Annual Meeting, where shareholders elected two Class II directors, Robert Golden and Andrew Zeinfeld, and ratified Withum Smith+Brown, PC as their independent accounting firm. The company also announced a significant reduction in liabilities and plans to launch an AI-driven search platform, contributing to a 311% share surge in the past six months.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
      "source": "Investing.com Nigeria",
      "category_within_source": "General",
      "source_domain": "Investing.com Nigeria",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.829708"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.727810"
        }
      ],
      "overall_sentiment_score": 0.340974,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.999082",
          "ticker_sentiment_score": "0.425200",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.644092",
          "ticker_sentiment_score": "0.333519",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet shareholders approve board elections and auditor at annual meeting",
      "url": "https://au.investing.com/news/sec-filings/onemednet-shareholders-approve-board-elections-and-auditor-at-annual-meeting-93CH-4183735",
      "time_published": "20251224T120929",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corp (NASDAQ:ONMD) held its 2025 Annual Meeting of Stockholders, where shareholders elected two Class II directors, Robert Golden and Andrew Zeinfeld, and ratified Withum Smith+Brown, PC as their independent registered public accounting firm. The company also appointed Dr. Kenneth Alleyne to the Compensation Committee. These developments follow a significant reduction in liabilities and plans to launch an AI-driven multimodal subscription search platform.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
      "source": "Investing.com Australia",
      "category_within_source": "General",
      "source_domain": "Investing.com Australia",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.849396"
        },
        {
          "topic": "finance",
          "relevance_score": "0.718280"
        },
        {
          "topic": "technology",
          "relevance_score": "0.620860"
        }
      ],
      "overall_sentiment_score": 0.336976,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.323094",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet shareholders approve board elections and auditor at annual meeting",
      "url": "https://www.investing.com/news/sec-filings/onemednet-shareholders-approve-board-elections-and-auditor-at-annual-meeting-93CH-4422031",
      "time_published": "20251224T120914",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet (NASDAQ:ONMD) shareholders approved the election of two Class II directors, Robert Golden and Andrew Zeinfeld, and ratified Withum Smith+Brown, PC as their independent accounting firm. The company, which is trading at $1.29 with a market capitalization of $66.31 million, also recently announced a significant reduction in total liabilities and plans to launch an AI-driven multimodal subscription search platform in early 2026. These developments highlight OneMedNet's efforts to enhance its offerings and market position.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.905328"
        },
        {
          "topic": "finance",
          "relevance_score": "0.810409"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.720161"
        },
        {
          "topic": "technology",
          "relevance_score": "0.601232"
        }
      ],
      "overall_sentiment_score": 0.379224,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.414489",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.616028",
          "ticker_sentiment_score": "0.316781",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet shareholders approve board elections and auditor at annual meeting",
      "url": "https://m.investing.com/news/sec-filings/onemednet-shareholders-approve-board-elections-and-auditor-at-annual-meeting-93CH-4422031?ampMode=1",
      "time_published": "20251223T220944",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corp (NASDAQ:ONMD) shareholders approved the election of two Class II directors, Robert Golden and Andrew Zeinfeld, and ratified Withum Smith+Brown, PC as their independent accounting firm at the 2025 Annual Meeting. The company has also recently appointed Dr. Kenneth Alleyne to the Compensation Committee and reported a significant reduction in liabilities, an expansion of its real-world data network, and plans to launch an AI-driven platform in early 2026. These developments highlight OneMedNet's efforts to enhance offerings and maintain its market position, despite facing financial challenges.",
      "banner_image": "https://i-invdn-com.investing.com/msite/img/install_apps/mobile-icon-banner.svg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.911190"
        },
        {
          "topic": "technology",
          "relevance_score": "0.812692"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.719502"
        }
      ],
      "overall_sentiment_score": 0.276564,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.957471",
          "ticker_sentiment_score": "0.346343",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.621178",
          "ticker_sentiment_score": "0.207125",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025",
      "url": "https://www.sahmcapital.com/news/content/onemednet-ceo-aaron-green-issues-letter-to-shareholders-highlighting-2025-2025-12-22",
      "time_published": "20251223T130854",
      "authors": [],
      "summary": "OneMedNet CEO Aaron Green issued a letter to shareholders detailing the company's 2025 achievements and future outlook. Key highlights include a significant reduction in liabilities, acceleration of their AI-powered platform with Palantir, and expansion of their healthcare provider network. The company aims to revolutionize Real-World Data access and capitalize on the growing demand for AI model training and regulatory-approved data.",
      "banner_image": null,
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.923580"
        },
        {
          "topic": "technology",
          "relevance_score": "0.809531"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.717553"
        }
      ],
      "overall_sentiment_score": 0.358601,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.414596",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.707560",
          "ticker_sentiment_score": "0.345181",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet reduces liabilities by 75% in 2025, plans AI platform launch",
      "url": "https://www.investing.com/news/company-news/onemednet-reduces-liabilities-by-75-in-2025-plans-ai-platform-launch-93CH-4419509",
      "time_published": "20251222T140930",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corporation significantly reduced its liabilities by 75% in 2025 and plans to launch an AI-driven multimodal subscription search platform in early 2026. The company reported an 8-fold increase in Q3 bookings year-over-year and expanded its healthcare provider network to 186 million clinical exams from over 2,130 partner sites. This move follows an integration with Palantir's AI platform and aims to address the critical bottleneck in accessing healthcare data for AI-driven healthcare.",
      "banner_image": "https://i-invdn-com.investing.com/news/world_news_2_69x52._800x533_L_1419494365.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.935791"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.810592"
        },
        {
          "topic": "technology",
          "relevance_score": "0.749794"
        },
        {
          "topic": "finance",
          "relevance_score": "0.624931"
        }
      ],
      "overall_sentiment_score": 0.410867,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.476734",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.608501",
          "ticker_sentiment_score": "0.312947",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Corporation Outlines Strategic Growth Plans and Highlights for 2025 in Shareholder Letter",
      "url": "https://www.quiverquant.com/news/OneMedNet+Corporation+Outlines+Strategic+Growth+Plans+and+Highlights+for+2025+in+Shareholder+Letter",
      "time_published": "20251222T140930",
      "authors": [],
      "summary": "OneMedNet Corporation released a shareholder letter from CEO Aaron Green, detailing impressive 2025 achievements and strategic plans for 2026. The company significantly reduced liabilities and partnered with Palantir to enhance its Real-World Data (RWD) platform, aiming to launch an AI-driven multimodal search tool. This initiative, alongside expanding its healthcare provider network, positions OneMedNet for substantial growth in the rapidly evolving healthcare data market.",
      "banner_image": "https://www.quiverquant.com/images/onmd_rect_new.png",
      "source": "Quiver Quantitative",
      "category_within_source": "General",
      "source_domain": "Quiver Quantitative",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.921096"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.814218"
        },
        {
          "topic": "technology",
          "relevance_score": "0.745576"
        },
        {
          "topic": "finance",
          "relevance_score": "0.646404"
        }
      ],
      "overall_sentiment_score": 0.374777,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.401695",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.623040",
          "ticker_sentiment_score": "0.315852",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Reports Strong Momentum and Industry Excitement at RSNA",
      "url": "https://www.sahmcapital.com/news/content/onemednet-reports-strong-momentum-and-industry-excitement-at-rsna-2025-12-10",
      "time_published": "20251210T150958",
      "authors": [],
      "summary": "OneMedNet Corporation announced significant engagement and growing commercial traction following a productive presence at the Radiological Society of North America (RSNA) Annual Meeting. The company's iRWD\u2122 platform, powered by Palantir Foundry, garnered strong interest from hospitals, imaging centers, and life sciences innovators due to its ability to provide high-quality, regulatory-grade Real-World Data and efficient deployment model. OneMedNet continues to expand its provider network and platform capabilities to deliver regulatory-grade RWD globally.",
      "banner_image": null,
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.911496"
        },
        {
          "topic": "technology",
          "relevance_score": "0.817007"
        },
        {
          "topic": "finance",
          "relevance_score": "0.641710"
        }
      ],
      "overall_sentiment_score": 0.001467,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.313910",
          "ticker_sentiment_score": "0.000030",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "OneMedNet reports growing commercial interest at RSNA 2025",
      "url": "https://www.investing.com/news/company-news/onemednet-reports-growing-commercial-interest-at-rsna-2025-93CH-4401164",
      "time_published": "20251210T150904",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corporation (NASDAQ:ONMD) reported increased commercial engagement at the Radiological Society of North America (RSNA) Annual Meeting, with hospitals, imaging centers, and life sciences companies showing interest in its iRWD platform. Despite strong stock performance and growing interest in its AI-powered real-world data network, the company faces financial challenges, including weak gross profit margins and unprofitability over the past year. OneMedNet continues to expand its network and strategic partnerships, including a multi-year agreement with Palantir Technologies.",
      "banner_image": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.907844"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.820339"
        },
        {
          "topic": "technology",
          "relevance_score": "0.720157"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.606788"
        }
      ],
      "overall_sentiment_score": 0.393198,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.412912",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.636197",
          "ticker_sentiment_score": "0.346564",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Corporation Reports Strong Engagement and Interest at RSNA 2025 Annual Meeting",
      "url": "https://www.quiverquant.com/news/OneMedNet+Corporation+Reports+Strong+Engagement+and+Interest+at+RSNA+2025+Annual+Meeting",
      "time_published": "20251210T140904",
      "authors": [],
      "summary": "OneMedNet Corporation reported strong engagement and commercial interest at the RSNA 2025 Annual Meeting for its iRWD\u2122 platform, powered by Palantir Foundry. Healthcare providers and life sciences organizations showed significant interest in the platform's high-quality, regulatory-grade Real-World Data, enhanced by AI-enabled cohort discovery. This feedback validates OneMedNet's strategy and positions the company for continued growth in supporting healthcare innovation and product development.",
      "banner_image": "https://quiverquantitative.box.com/shared/static/jy9hjdu83k2w3df2we0vsstro4yp6rxx.jpg",
      "source": "Quiver Quantitative",
      "category_within_source": "General",
      "source_domain": "Quiver Quantitative",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.903089"
        },
        {
          "topic": "technology",
          "relevance_score": "0.843510"
        },
        {
          "topic": "finance",
          "relevance_score": "0.622781"
        }
      ],
      "overall_sentiment_score": 0.358969,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.437961",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.735478",
          "ticker_sentiment_score": "0.344616",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Secures Strong Position with Groundbreaking Data Platform",
      "url": "https://stockstotrade.com/news/onemednetcorp-onmd-news-2025_11_29/",
      "time_published": "20251203T130944",
      "authors": [
        "Tim Bohen",
        "Ben Sturgill",
        "Ellis Hobbs"
      ],
      "summary": "OneMedNet (ONMD) is experiencing a significant surge, with its stock up 19.72% due to positive market sentiment and advancements in its AI-ready Real-World Data platform, developed on Palantir Foundry. Despite historical financial challenges like a negative EBIT margin and low revenue, the company has seen an 815% increase in Q3 bookings and a massive expansion of its provider network, indicating a promising turnaround and growth potential in AI-powered healthcare analytics. The article suggests monitoring for a breakout above the 1.71 resistance level for traders.",
      "banner_image": "https://content.stockstotrade.com/wp-content/uploads/2025/11/innovative-healthcare-data-platform-growth.png",
      "source": "StocksToTrade",
      "category_within_source": "General",
      "source_domain": "StocksToTrade",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.942570"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.849380"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.944275"
        },
        {
          "topic": "technology",
          "relevance_score": "0.838188"
        },
        {
          "topic": "finance",
          "relevance_score": "0.627955"
        }
      ],
      "overall_sentiment_score": 0.316933,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.263752",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.604401",
          "ticker_sentiment_score": "0.334422",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Corp Advances with Strong Platform Validation and Network Expansion",
      "url": "https://stockstotrade.com/news/onemednetcorp-onmd-news-2025_11_30/",
      "time_published": "20251201T044316",
      "authors": [
        "Tim Bohen",
        "Ben Sturgill",
        "Ellis Hobbs"
      ],
      "summary": "OneMedNet Corp (ONMD) has seen its stock rise by 19.72% due to strong platform validation, a significant network expansion, and an 815% surge in Q3 bookings. Despite these advancements and a strategic partnership with Palantir, the company faces severe financial challenges, including negative profitability ratios and liquidity issues. The article suggests cautious optimism in light of strategic growth alongside persistent financial vulnerabilities.",
      "banner_image": "https://content.stockstotrade.com/wp-content/uploads/2025/11/dynamic-stock-market-growth-trends-252.png",
      "source": "StocksToTrade",
      "category_within_source": "General",
      "source_domain": "StocksToTrade",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.943725"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.834576"
        },
        {
          "topic": "technology",
          "relevance_score": "0.749969"
        }
      ],
      "overall_sentiment_score": 0.183179,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.032252",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.634983",
          "ticker_sentiment_score": "0.332329",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet Corp director Yu buys $959k in shares",
      "url": "https://www.investing.com/news/insider-trading-news/onemednet-corp-director-yu-buys-959k-in-shares-93CH-4380803",
      "time_published": "20251201T044316",
      "authors": [
        "Investing.com"
      ],
      "summary": "OneMedNet Corp Director Jeffrey Yu purchased shares totaling $959,585 in multiple transactions between June and September 2025, with prices ranging from $0.42 to $1.03. These transactions included direct stock purchases, conversions of Senior Secured Convertible Notes and shareholder loans, and receipt of restricted stock units. Following these acquisitions, Yu now directly owns 7,326,223 shares of OneMedNet Corp, in addition to indirectly held shares for his children.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.934721"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.729180"
        }
      ],
      "overall_sentiment_score": 0.357279,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.409129",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.614980",
          "ticker_sentiment_score": "0.326046",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Will OneMedNet\u2019s Momentum Keep Going?",
      "url": "https://stockstotrade.com/news/onemednet-corp-onmd-news-2025_11_28/",
      "time_published": "20251127T140923",
      "authors": [
        "Tim Bohen",
        "Ben Sturgill",
        "Ellis Hobbs"
      ],
      "summary": "OneMedNet Corp stock trading surged by 46.83% following new FDA clearances and the introduction of a revamped data exploration feature and network expansion. Despite significant financial challenges including negative profit margins and substantial debt, the company secured an 815% increase in bookings due to strategic partnerships and a shift towards a SaaS subscription model. The article analyzes whether these positive developments indicate sustainable growth for OneMedNet amidst its financial struggles.",
      "banner_image": "https://content.stockstotrade.com/wp-content/uploads/2025/11/dynamic-healthcare-stock-market-trends-2.png",
      "source": "StocksToTrade",
      "category_within_source": "General",
      "source_domain": "StocksToTrade",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.909042"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.827272"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.719293"
        }
      ],
      "overall_sentiment_score": 0.230616,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.258299",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.638707",
          "ticker_sentiment_score": "0.152902",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "OneMedNet (Nasdaq: ONMD) RSNA Demo Highlights 2,130 Sites, 47M Patients Globally",
      "url": "https://www.stocktitan.net/news/ONMD/one-med-net-to-showcase-transformative-new-platform-at-rsna-qjcrh2hru48e.html",
      "time_published": "20251125T160947",
      "authors": [
        "NULL"
      ],
      "summary": "OneMedNet (Nasdaq: ONMD) is set to demonstrate its newly redesigned data exploration and cohort-building platform at RSNA 2025, following positive feedback from customers and prospects at ISPOR Europe. Built on Palantir Foundry and AIP, the platform connects to OneMedNet\u2019s iRWD network, which includes over 2,130 provider sites, 47 million unique patient lives, and 186 million clinical exams and images. Key enhancements include faster cohort feasibility, AI-driven natural-language search, real-time longitudinal insights, and integrated subscription workflows to support recurring revenue.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.910038"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.848001"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.711178"
        },
        {
          "topic": "finance",
          "relevance_score": "0.601313"
        }
      ],
      "overall_sentiment_score": 0.027563,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.322012",
          "ticker_sentiment_score": "0.042194",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "OneMedNet (Nasdaq: ONMD) Grows RWD Network 38% as Subscription Model Scales",
      "url": "https://www.stocktitan.net/news/ONMD/one-med-net-accelerates-subscription-revenue-strategy-with-industry-l70aild7c581.html",
      "time_published": "20251122T150907",
      "authors": [],
      "summary": "OneMedNet (Nasdaq: ONMD) announced a significant expansion of its iRWD network on November 20, 2025, increasing patient records by 38% to over 47 million and clinical exams by 37% to over 186 million. This growth, which also included a 22% rise in provider sites, is intended to strengthen its subscription model and accelerate recurring revenue in the estimated $60 billion Real-World Evidence market. Despite the positive network expansion, the company's stock declined by 10.66% on the day of the announcement, reflecting a negative market reaction.",
      "banner_image": "https://www.globenewswire.com/newsroom/ti?nf=OTU3OTU4NSM3Mjc1MTU0IzIyNjMyNTE=",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.932231"
        },
        {
          "topic": "technology",
          "relevance_score": "0.849991"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.707011"
        }
      ],
      "overall_sentiment_score": -0.354331,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.371746",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "OneMedNet (Nasdaq: ONMD) posts Q3 bookings of $1.1M and $14.3M liability reductions",
      "url": "https://www.stocktitan.net/news/ONMD/one-med-net-reports-815-bookings-increase-and-4-5x-increase-in-h7tyf30gbl9z.html",
      "time_published": "20251117T074500",
      "authors": [
        "NULL"
      ],
      "summary": "OneMedNet (Nasdaq: ONMD) reported a significant operational and financial improvement for Q3 2025, including a 815% year-over-year increase in bookings to $1.1M and a year-to-date total liability reduction of $14.3M. The company also announced a 4.5x increase in inbound demand and launched a Palantir-powered SaaS subscription model to build recurring revenue. These initiatives aim to strengthen the balance sheet and accelerate growth by converting demand into recognized, recurring revenue.",
      "banner_image": "https://ml.globenewswire.com/media/NzBmNWI3NGEtNzAxYS00ZTI1LTlkNzQtOTEzYzJjNzNhZDM2LTEyNzQ4MDEtMjAyNS0xMS0xNy1lbg==/tiny/OneMedNet-Corporation.png",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "technology",
          "relevance_score": "0.829880"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.713166"
        }
      ],
      "overall_sentiment_score": 0.416659,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.493664",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.612289",
          "ticker_sentiment_score": "0.319988",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Palantir: The UK Deal That Might Ignite Its Next Growth Phase - TradingView",
      "url": "https://www.tradingview.com/news/gurufocus:74dafed8a094b:0-palantir-the-uk-deal-that-might-ignite-its-next-growth-phase/",
      "time_published": "20251017T140524",
      "authors": [],
      "summary": "Palantir recently secured a significant strategic partnership in the UK, involving up to 1.5 billion in investment and a new London defense headquarters, which management believes could drive future NATO and European MoD growth. The company reported several new contract wins and lifted its fiscal 2025 targets, with investors awaiting Q3 results. Despite strong international government potential, Palantir faces challenges in its international commercial segment and regulatory headwinds in Europe.",
      "banner_image": null,
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.947677"
        },
        {
          "topic": "technology",
          "relevance_score": "0.830626"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.747001"
        }
      ],
      "overall_sentiment_score": 0.024508,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.326687",
          "ticker_sentiment_score": "0.013637",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "OneMedNet Corporation May Not Have A Competitive Product And Does Not Deserve A 200x Sales Multiple - Seeking Alpha",
      "url": "https://seekingalpha.com/article/4830143-onemednet-corporation-may-not-have-a-competitive-product-and-does-not-deserve-a-200x-sales-multiple",
      "time_published": "20251015T154235",
      "authors": [
        "Quipus Capital"
      ],
      "summary": "This article analyzes OneMedNet Corporation (ONMD), a medical records data management company, highlighting its rapid revenue growth but minuscule annual revenues under $0.5 million. The author expresses concerns about ONMD's lack of competitive advantage, struggles with market traction, deep unprofitability, and reliance on shareholder dilution for funding. Given its high 200x+ price-to-sales ratio and operational weaknesses, the stock is rated as a Hold due to high risk and low liquidity.",
      "banner_image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1332536720/image_1332536720.jpg?io=getty-c-w750",
      "source": "Seeking Alpha",
      "category_within_source": "General",
      "source_domain": "Seeking Alpha",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.939200"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.832567"
        },
        {
          "topic": "finance",
          "relevance_score": "0.619392"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.517208"
        }
      ],
      "overall_sentiment_score": 0.001579,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.318719",
          "ticker_sentiment_score": "0.000786",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "OneMedNet (NASDAQ:ONMD) Given Sell (D-) Rating at Weiss Ratings - Defense World",
      "url": "https://www.defenseworld.net/2025/10/15/onemednet-nasdaqonmd-given-sell-d-rating-at-weiss-ratings.html",
      "time_published": "20251015T073417",
      "authors": [
        "Defense World Staff"
      ],
      "summary": "Weiss Ratings has assigned OneMedNet (NASDAQ:ONMD) a \"Sell (D-)\" rating in a recent research note. The article also highlights that Exencial Wealth Advisors LLC increased its stake in OneMedNet. The company provides clinical imaging solutions with its iRWD platform for medical research.",
      "banner_image": null,
      "source": "Defense World",
      "category_within_source": "General",
      "source_domain": "Defense World",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.916489"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.828881"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.723224"
        },
        {
          "topic": "technology",
          "relevance_score": "0.431735"
        }
      ],
      "overall_sentiment_score": 0.001915,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "ONMD",
          "relevance_score": "0.330979",
          "ticker_sentiment_score": "0.000884",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    }
  ]
}